Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (507)	2/22/1999 5:14:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 4474

I didn't go that far...but I feel your pain;-) Thread: What follow is a lot of chit chat, so just disregard if noise bothers you. I needed a bit more cash to put together an order to get 1000 Curagen the other day...I looked up and down my portfolio for something that was pissing me off, and so I took 1500 of my 3000 Ariad off the table. The slow steady weakness the stock has shown lately was part of the reason too--I thought we were through the worst part...and then the volume petered out too! Sounds like you got an okay price on your warrants-- in fact, I'm a bit surprised you did that well. Actually, I wanted to retain some exposure to the possibility of big news, and perhaps an extension for the warrants--so even though I ended up lightening up in the common, I grabbed some more ariaw on the cheap for 5/32 a week ago or so--I figure Ariad management shows little interest in propping up the common with these convertable giveaways so they are just as likely to extend the warrants as well, in which case they are probably pretty cheap in here...I wouldn't pay 1/4, but 5/32 not too shabby. I didn't get too many ariaw tho, net result was to put $800 back in the warrants, and take about $2800 out of the common. Speaking of Viragen now...I only had 1000 shares at 3/4ths, but even that trivial amount was too much. Looks like Braveheart is turning negative on that one too today. Message 7961670 As far as PARS...while I was getting my new Rx eyeglasses the other day, I left the most recent PR with the Optomitrist, to give to her husband the Opthamologist. I've stripped off the name, but these were the comments he emailed to me, for what it is worth... PARS: there are several allergy drops that are as efficacious as Lotemax. I dont see how Pharmos' market share will increase very dramatically. And ophthalmologists account for only a small percentage of actual ocular prescriptions written; most patients will by choice or design (i.e. HMOS) be funneled through their GP who will then prescribe an eyedrop. I don't think he will mind me posting the comments, I'm sure he would say worth two cents/do your own DD, but that was all I needed to see to unbookmark PARS from my watch list, besides, I have a little trading gain in that, maybe better to just walk away. fyi, CRGN...I downloaded the latest patent, it suggested to me that maybe Curagen has put together a nice little system...and while I most certainly do not understand 90% of what the patent describes, I didn't see anything to scare me off. I basically flipped a coin between glgc and crgn...and went with the latter.